Stents Market 2016 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast to 2020

PUNE, INDIA, July 14, 2016 /EINPresswire.com/ -- According to researcher, the Global Stents Market is valued at $8.43 billion in 2015 and is projected to grow to $12.13 billion by 2022 growing at a Compound Annual Growth Rate of 5.3%. Rising adoption of drug-eluting stents as a more efficient treatment for coronary heart disease, coupled with growing awareness among patients about stents, is anticipated to fuel the market growth. On the other hand strict regulations for approval of stents, abridged reimbursement and substitute methods and are hampering the market. The innovation of technological advanced products with lower re-stenosis occurrence rates such as bio-absorbable stents and the existence of high unmet medical needs in emerging Asian countries are some of the future growth opportunities of this market.

Complete report details @ https://www.wiseguyreports.com/reports/stents-global-market-outlook-2015-2022

Bare metal stents segment anticipated to have a turn down in revenue during the forecast period. Bio-absorbable stents segment is estimated to witness the highest CAGR during the forecast period. By Application, urological stents segment dominates the market and accounts for more than 50% market share. The global stent market is mostly controlled by three players Abbott Laboratories, Medtronic and Boston Scientific. However, small and medium companies from Asia and Europe have a significant share in terms of volume in developing economies.
Some of the key players in the market are Medtronic, Abbott Laboratories, Arterius, B. Braun, Biosensors International, Biotronik, Boston Scientific Corp., C.R. Bard Inc., Celonova Biosciences, Cook Medical, Cordis Corp., Covidien, Elixir Medical Corp., Inspiremd and Kyoto Me.

Request a free sample report @ https://www.wiseguyreports.com/sample-request/stents-global-market-outlook-2015-2022

Device Covered:
• Drug-Eluting Stents
• Bioresorbable Stents
• Bare-Metal Stents
• Others
o Plastic Stents
o Self Expanding metal Stents
Application Covered:
• Vascular stents
o Coronary Stents
o Peripheral stents
o Peripheral Lower-Extremity Arterial Stents Gastrointestinal Stents
o Iliac Artery Stents
o Neurovascular Stents
 Carotid Stents
 Intracranial stents
o Renal Artery Stents
• Non-vascular stents
• Urology
o Prostate stents
o Ureteral & Urethral stents
• Ophthalmology
• Gastrointestinal
o Colorectal
o Duodenal stents
o Esophageal
o Pancreatic & Biliary
• Airway
• Others

Materials Covered:
• Polymers
o Bio-absorbable polymers
o Durable polymer
• Metals
o Nickel-titanium
o Cobalt-chromium
o Stainless steel
o Platinum-chromium
o Others
Coatings Covered:
• Coated stents
o Inorganic
o Polymer
o Polymer-free
o Other coated stents
• Non-coated stents
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/stents-global-market-outlook-2015-2022


Table of content
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Stents Market, By Device
5.1 Introduction
5.2 Drug-Eluting Stents
5.3 Bioresorbable Stents
5.4 Bare-Metal Stents
5.5 Others
5.5.1 Plastic Stents
5.5.2 Self Expanding metal Stents

6 Global Stents Market, By Application
6.1 Introduction
6.2 Vascular stents
6.2.1 Coronary Stents
6.2.2 Peripheral stents
6.2.2.1 Peripheral Lower-Extremity Arterial Stents
6.2.2.2 Iliac Artery Stents
6.2.2.3 Neurovascular Stents
6.2.2.3.1 Carotid Stents
6.2.2.3.2 Intracranial stents
6.2.2.4 Renal Artery Stents
6.3 Non-vascular stents
6.3.1 Urology
6.3.1.1 Prostate stents
6.3.1.2 Ureteral & Urethral stents
6.3.2 Ophthalmology
6.3.3 Gastrointestinal
6.3.3.1 Colorectal
6.3.3.2 Duodenal stents
6.3.3.3 Esophageal
6.3.3.4 Pancreatic & Biliary
6.3.4 Airway
6.3.5 Others

7 Global Stents Market, By Materials
7.1 Polymers
7.1.1 Bio-absorbable polymers
7.1.2 Durable polymer
7.2 Metals
7.2.1 Nickel-titanium
7.2.2 Cobalt-chromium
7.2.3 Stainless steel
7.2.4 Platinum-chromium
7.2.5 Others

8 Global Stents Market, By Coatings
8.1 Coated stents
8.1.1 Inorganic
8.1.2 Polymer
8.1.3 Polymer-free
8.1.4 Other coated stents
8.2 Non-coated stents

9 Global Stents Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 Newzealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Medtronic
11.2 Abbott Laboratories
11.3 Arterius
11.4 B. Braun
11.5 Biosensors International
11.6 Biotronik
11.7 Boston Scientific Corp.
11.8 C.R. Bard Inc.
11.9 Celonova Biosciences
11.10 Cook Medical
11.11 Cordis Corp.
11.12 Covidien
11.13 Elixir Medical Corp.
11.14 Inspiremd
11.15 Kyoto Me

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=339148

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.